0 followers
Ankasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a sig... Read more
Sanford J. Madigan
Lawrence Livermore National Laboratory
4 followers
Lumanity
2 followers
University of Colorado Cancer Center
1 follower
Skool
3 followers
Council on Foreign Relations
75 followers
Anthropic
49 followers
MediaRadar
8 followers
Mochi
1 follower
The Heritage Foundation
4 followers
Codeium
6 followers
IPD Analytics
3 followers
Explore companies